Stay updated on Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA dedicated Locations section was added listing North Carolina as a participating site. The page revision updates from v3.3.2 to v3.3.3 and removes the previous North Carolina location entry along with the HHS Vulnerability Disclosure link.SummaryDifference0.3%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now displays Revision: v3.3.2 and no longer shows Revision: v3.2.0.SummaryDifference0.1%

- Check48 days agoChange DetectedThe notice about government funding status and NIH operating updates has been removed from the page. Core study details and navigation remain unchanged.SummaryDifference0.5%

- Check63 days agoChange DetectedThe new screenshot shows a redesigned layout and navigation while the core study details remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange DetectedMajor update: page now includes a government funding/operating-status notice (high-importance core content) and switches from version v3.1.0 to v3.2.0.SummaryDifference6%

- Check98 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.2%

Stay in the know with updates to Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.